8-BrcAMP does not affect Na-K-2Cl cotransport in winter flounder intestine.
The flounder intestinal epithelium possesses luminal Na-K-2Cl cotransport and K secretory mechanisms that account for the short-circuit current (Isc) across the tissue. This epithelium is also highly cation selective. Bumetanide or 8-bromoguanosine 3',5'-cyclic monophosphate (8-BrcGMP) completely inhibit Isc, Na-K-2Cl cotransport, and K secretion, whereas 8-bromoadenosine 3',5'-cyclic monophosphate (8-BrcAMP) inhibits K secretion, partially inhibits Isc, and greatly increases Cl permeability. Although the direct effects of adenosine 3',5'-cyclic monophosphate (cAMP) on other Na-K-2Cl cotransport systems have been examined, the effects of 8-BrcAMP on flounder intestinal Na-K-2Cl cotransport have not been directly measured. In this study, the effects of 8-BrcAMP and bumetanide, either alone or in combination, on the influx (initial rates of uptake) of Cl, Rb, and Na across the luminal surface of the flounder intestine were examined. Bumetanide significantly inhibited Na (50%), Cl, and Rb influx (70% each). In contrast, 8-BrcAMP significantly increased Cl influx in the presence or absence of bumetanide and thereby did not effect the bumetanide-sensitive Cl influx. The nucleotide neither altered bumetanide-sensitive Rb influx nor net transpithelial Na absorption measured under short-circuit conditions but caused a 51-60% decrease in Isc. Measurements of bumetanide-sensitive Na influx exhibited large experimental variability but showed no statistically significant effects of 8-BrcAMP. Prostaglandin E1 (PGE1, 10 microM) and forskolin (10 microM) but not atrial natriuretic factor (1 microM) increased flounder intestinal [cAMP] 200 and 237%, respectively, and, like 8-BrcAMP, increased tissue conductance.(ABSTRACT TRUNCATED AT 250 WORDS)
Rao
M C
MC
Department of Physiology and Biophysics, University of Illinois College of Medicine, Chicago 60612.
Nash
N T
NT
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology*; D000818:Animals; D002034:Bumetanide / Q000494:pharmacology; D002352:Carrier Proteins / Q000378:metabolism*; D002712:Chlorides / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism; D005432:Flounder; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000187:drug effects; D007700:Kinetics; D012413:Rubidium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism*; D028021:Sodium-Potassium-Chloride Symporters
D002352:Carrier Proteins; D002712:Chlorides; D028021:Sodium-Potassium-Chloride Symporters; D002034:Bumetanide; D015124:8-Bromo Cyclic Adenosine Monophosphate; D012964:Sodium; D000242:Cyclic AMP; D012413:Rubidium